Stay updated with breaking news from Panetta Partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON and NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is developing
Investegate announcements from OKYO Pharma Limited, Director Acquires Shares
Investegate announcements from OKYO Pharma LTD, OKYO Pharma Today Announces Director Acquires Shares
LONDON and NEW YORK, March 29, 2023 -- OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease to address the significant... | March 29, 2023
Director acquires shares London and New York, NY, 29 March, 2023 - OKYO Pharma Limited , an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat... | March 29, 2023